https://www.selleckchem.com/pr....oducts/piperlongumin
This review article discusses the known genetics of cardiomyopathies in dogs, reviews existing gene therapy strategies and the status of their development in canines, and discusses ongoing challenges in the clinical translation of these technologies for treating heart disease. While challenges remain in using these emerging technologies, the exponential growth of the gene therapy field holds great promise for future clinical applications. Core needle biopsies (CNBs) have proven to be an excellent source of tissue for diagnosis an
お気に入り
コメント
シェア
